Bintrafusp alfa, a bifunctional fusion protein targeting PD-L1 and TGF-β, has shown promise in various cancers, including CRC (117), lung cancer (118), biliary tract cancer (119), and cervical cancer (120). This evidence concerns the gene CD274 and colorectal carcinoma.